C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	59.65	126.59	29.75	76.12	181.73	90.55
Short-Term Investments	195.99	127.09	246.4	233.16	189.96	-
Cash & Short-Term Investments	255.64	253.68	276.15	309.28	371.69	90.55
Cash Growth	18.04%	-8.14%	-10.71%	-16.79%	310.48%	149.37%
Receivables	10.34	11.8	1.47	5.72	4.48	4.62
Prepaid Expenses	7.25	5.71	9.93	10.69	4.84	1.6
Total Current Assets	273.23	271.19	287.56	325.69	381.01	96.77
Property, Plant & Equipment	65.37	71.09	77.52	35.05	16.55	18.92
Long-Term Investments	28.76	28.01	60.96	142.2	-	-
Other Long-Term Assets	8.7	6.17	4.81	3.82	2.58	2.58
Total Assets	376.06	376.45	430.84	506.77	400.14	118.26
Accounts Payable	1.5	1.45	1.17	4.51	5.68	5.39
Accrued Expenses	13.57	15.49	16.66	13.19	9.06	6.39
Current Portion of Long-Term Debt	-	-	2.29	-	-	-
Current Portion of Leases	5.63	5.22	4.7	1.33	1.04	0.88
Current Unearned Revenue	20.77	15.47	16.62	31.8	27.6	20.71
Other Current Liabilities	1.82	5.14	3.11	0.41	0.47	0.28
Total Current Liabilities	43.29	42.77	44.55	51.25	43.85	33.64
Long-Term Debt	-	-	9.2	10.77	10.05	-
Long-Term Leases	61.46	65.76	70.97	30.78	11.83	12.87
Long-Term Unearned Revenue	28.65	21.81	16.9	24.37	53.62	72.72
Total Liabilities	133.4	130.34	141.61	117.16	119.35	119.23
Common Stock	0.01	0.01	0.01	0.01	0	-
Additional Paid-In Capital	841.32	774.62	689.26	658.09	464.6	5.53
Retained Earnings	-599.13	-528.38	-395.89	-267.72	-183.82	-117.49
Comprehensive Income & Other	0.46	-0.13	-4.14	-0.78	0.01	-
Total Common Equity	242.66	246.11	289.23	389.61	280.79	-111.96
Shareholders' Equity	242.66	246.11	289.23	389.61	280.79	-0.97
Total Liabilities & Equity	376.06	376.45	430.84	506.77	400.14	118.26
Total Debt	67.1	70.98	87.15	42.88	22.92	13.75
Net Cash (Debt)	217.31	210.71	249.96	408.6	348.77	76.8
Net Cash Growth	24.71%	-15.70%	-38.82%	17.15%	354.13%	251.83%
Net Cash Per Share	3.37	4.24	5.12	8.87	30.67	55.98
Filing Date Shares Outstanding	70.59	68.6	49.05	48.74	43.12	1.43
Total Common Shares Outstanding	70.56	60.47	48.97	48.69	43.06	1.43
Working Capital	229.94	228.42	243.01	274.44	337.16	63.13
Book Value Per Share	3.44	4.07	5.91	8.00	6.52	-78.48
Tangible Book Value	242.66	246.11	289.23	389.61	280.79	-111.96
Tangible Book Value Per Share	3.44	4.07	5.91	8.00	6.52	-78.48
Machinery	10.37	10.18	10.66	9.48	8.41	7.9
Construction In Progress	-	-	0.18	-	-	-
Leasehold Improvements	4.71	4.71	4.68	0.54	0.54	0.52

Source: S&P Capital IQ. Standard template. Financial Sources.